Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 17/20 | 0.69 |
| ▸ | PTAFR | P25105 | 1/20 | 0.66 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.61 |
| ▸ | MMP3 | P08254 | 1/20 | 0.58 |
| ▸ | MMP7 | P09237 | 1/20 | 0.58 |
| ▸ | MMP10 | P09238 | 1/20 | 0.58 |
| ▸ | MMP8 | P22894 | 1/20 | 0.58 |
| ▸ | MMP12 | P39900 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3666267 | 1.00 | HRH3 (0.69) | HRH3PTAFRUSP30MMP3MMP7 | |
| SCHEMBL4937732 | 0.95 | PTAFR (0.71) | HRH3PTAFRUSP30MMP3MMP7 | |
| SCHEMBL3636143 | 0.85 | HRH3 (0.71) | HRH3USP30KCNH2 | |
| SCHEMBL4937758 | 0.85 | HRH3 (0.71) | HRH3USP30KCNH2 | |
| SCHEMBL3636148 | 0.85 | HRH3 (0.71) | HRH3USP30KCNH2 | |
| SCHEMBL3809256 | 0.84 | HRH3 (0.60) | HRH3PTAFRMMP3MMP7MMP10 | |
| SCHEMBL4937165 | 0.84 | HRH3 (0.69) | HRH3USP30 | |
| SCHEMBL3736390 | 0.84 | HRH3 (0.69) | HRH3USP30 | |
| SCHEMBL4938137 | 0.82 | USP30 (0.62) | HRH3USP30 | |
| SCHEMBL4937089 | 0.82 | MMP7 (0.69) | HRH3PTAFRUSP30MMP3MMP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2155719-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | Wyeth LLC (US) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008147945-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | WYETH (US) | 2008-12-04 | — | — | WO | disclosed |
| US-20080293771-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | WYETH (US) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293771-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | HRH4, HRH3, HRH2 | HRH3 2/4885PTAFR 841/4885USP30 2123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.